Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Systems-level genetic patterns underlying disseminated coccidioidomycosis in humans

Award Number: R21AI152394
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/06/2020
PERIOD OF PERFORMANCE END DATE: 09/30/2022

Group Awards By:

View Award Description

Systems-level genetic patterns underlying disseminated coccidioidomycosis in humans - PROJECT SUMMARY Disseminated coccidioidomycosis (DCM) is a rare and potentially life-threatening consequence of infection with a desert soil dwelling fungal pathogen native to the Southwestern USA (Coccidioides spp.). The reason why a subset (<5%) of otherwise healthy people develop this adverse outcome after infection while most others do not is largely unknown. However, evidence points to genetics, primarily involving variation in the immune system. To discover the systems genetic patterns and pathways associated with DCM, we will examine the differential distribution of variants in biologically meaningful gene sets at genome-wide scale to find patterns that underlie disease susceptibility. Focusing on aggregated systems-level sets allows us to find patterns in the presence of cross-patient differences, and substantially increases our statistical discovery power by reducing the number of features being directly tested. This study will be the first of its scope and kind, using the largest cohort ever assembled for this disease (DNA collected from 147 susceptible DCM cases and 388 resistant controls presenting as self-limited pulmonary coccidioidomycosis). The data and results gathered under this proposal thus present a unique resource to lay important foundations for the study of DCM pathogenesis. The DNA has been both (i) genome-wide genotyped for common variation, and (ii) exome sequenced to look for rare, protein-altering variation. In our first Aim, we will study the genotype data in three different ways. First, we will look for association between DCM and variation in the human leukocyte antigen region (HLA) which plays an important role in many infectious diseases. Second, we will look at the distribution of patient genotypes at infection-relevant reQTL variant sets to model if DCM versus PUL have differences correlated with their phenotype. These reQTL variant sets are groups of DNA positions where different alleles can cause stronger or weaker gene expression responses after infection or stimulation, and differences between DCM and PUL at those positions could imply that their Coccidioides-response capacity may differ. Third, we will conduct a pathway-association study using both hypothesis-driven and unbiasedly selected pathways (sets of genes) to see if these genesets are enriched for variants associated with DCM. For our second Aim, we will analyze the rare variants found in patient exomes to compare whether DCM participants have an excess of rare and protein-damaging mutations in immune or other candidate pathways. We will use a two-step version of the small sample size optimized Sequence Kernel Association test, comparing the distribution of these mutations between DCM and PUL participants. Using a pathway, or gene set approach allows us to look at differentially impacted systems, rather than requiring each participant to carry the same single-gene mutation. Results of the studies under these two aims will lead to a better understanding the human genetic variation associated with DCM, will help us understand this emerging infectious disease (NIAID Category C), identify people at lower or higher risk, and ultimately build towards improvements in clinical care and patient experience.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2021	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Allergy and Infectious Diseases Research	000	2	10/16/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Allergy and Infectious Diseases Research	000	2	9/13/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $204,162 )
2021	2021	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Allergy and Infectious Diseases Research	001	2	3/15/2021	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$204,162
2021	2021	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Allergy and Infectious Diseases Research	003	2	7/14/2021	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$81,889
2021	2020	UNIVERSITY OF ARIZONA	888 N EUCLID AVE RM 510	TUCSON	AZ	85719	PIMA	USA	Allergy and Infectious Diseases Research	000	1	3/15/2021	NEW	$0
2021	2020	UNIVERSITY OF ARIZONA	888 N EUCLID AVE RM 510	TUCSON	AZ	85719	PIMA	USA	Allergy and Infectious Diseases Research	002	1	7/14/2021	NEW	-$81,889
														Subtotal = $204,162

Issue Date FY: 2020 ( Subtotal = $244,304 )
2020	2020	UNIVERSITY OF ARIZONA	888 N EUCLID AVE RM 510	TUCSON	AZ	85719	PIMA	USA	Allergy and Infectious Diseases Research	000	1	3/6/2020	NEW	$244,304
														Subtotal = $244,304

Grand Total All Awards = $448,466

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Systems-level genetic patterns underlying disseminated coccidioidomycosis in humans

Award Number: R21AI152394

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/06/2020

PERIOD OF PERFORMANCE END DATE: 09/30/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer